No evidence for association between the interferon regulatory factor 1 (IRF1) gene and clinical tuberculosis

Tuberculosis

Volumn 89, Issue 1, 2009, Pages 71-76

  Vollstedt, Sabine ^a,b   Yuliwulandari, Rika ^b,c   Okamoto, Koji ^b   Lien, Luu Thi ^d   Keicho, Naoto ^e   Rochani, Jecti Teguh ^c   Wikaningrum, Riyani ^c   Tokunaga, Katsushi ^b  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c YARSI UNIVERSITY   (Indonesia)

^d Hanoi Tuberculosis and Lung Disease Hospital   (Viet Nam)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Interferon regulatory factor 1 (IRF1); Tuberculosis

Indexed keywords

INTERFERON REGULATORY FACTOR 1;

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENOTYPE; HAPLOTYPE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDONESIA; INTERFERON REGULATORY FACTOR-1; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TUBERCULOSIS, PULMONARY; VIETNAM; YOUNG ADULT;

EID: 58149109037     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2008.09.006     Document Type: Article

References (49)

1. Abel B., Thieblemont N., Quesniaux V.J., Brown N., Mpagi J., Miyake K., et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol 169 6 (2002) 3155-3162
2. Aderem A., and Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 406 6797 (2000) 782-787
3. Akahoshi M., Nakashima H., Miyake K., Inoue Y., Shimizu S., Tanaka Y., et al. Influence of interleukin-12 receptor beta1 polymorphisms on tuberculosis. Hum Genet 112 3 (2003) 237-243
4. Bashirova A., Markelov M.L., Shlykova T.V., Alibaeva R.A., and Frolova E.I. The human RIL gene: mapping to human chromosome 5q31.1, genomic organization and alternative transcripts. Gene 210 2 (1998) 239-245
5. Borm G.F., den Heijer M., and Zielhuis G.A. Publication bias was not a good reason to discourage trials with low power. J Clin Epidemiol (2008) [Epub ahead of print]
6. Carpenter S., and O'Neill L.A. How important are toll-like receptors for antimicrobial responses?. Cell Microbiol 9 8 (2007) 1891-1901
7. Caylà J.A., Plasència A., Galdós-Tanguis H., and Jansà J.M. Pulmonary tuberculosis in HIV-infected patients as criterion for AIDS in Europe. Lancet 342 8862 (1993) 50
8. Chang J.S., Huggett J.F., Dheda K., Kim L.U., Zumla A., and Rook G.A. Mycobacterium tuberculosis induces selective up-regulation of TLRs in the mononuclear leukocytes of patients with active pulmonary tuberculosis. J Immunol 176 5 (2006) 3010-3018
9. Fantuzzi G., Reed D., Qi M., Scully S., Dinarello C.A., and Senaldi G. Role of interferon regulatory factor-1 in the regulation of IL-18 production and activity. Eur J Immunol 31 2 (2001) 369-375
10. Fraser D.A., Bulat-Kardum L., Knezevic J., Babarovic P., Matakovic-Mileusnic N., Dellacasagrande J., et al. Interferon-gamma receptor-1 gene polymorphism in tuberculosis patients from Croatia. Scand J Immunol 57 5 (2003) 480-484
11. Frieden T.R., Sterling T.R., Munsiff S.S., Watt C.J., and Dye C. Tuberculosis. Lancet 362 9387 (2003) 887-899
12. Graham R.R., Kozyrev S.V., Baechler E.C., Reddy M.V., Plenge R.M., Beuer J.W., et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38 5 (2006) 550-555
13. Gomez L.M., Sanchez E., Ruiz-Narvaez E.A., Lopez-Nevot M.A., Araya J.M., and Martin J. Macrophage migration inhibitory factor gene influences the risk of developing tuberculosis in northwestern Colombian population. Tissue Antigens 70 1 (2007) 28-33
14. Harada H., Takahashi E., Itoh S., Harada K., Hori T.A., and Taniguchi T. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol Cell Biol 14 2 (1994) 1500-1509
15. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu Rev Immunol 20 (2002) 197-216
16. Janis E.M., Kaufmann S.H., Schwartz R.H., and Pardoll D.M. Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis. Science 244 4905 (1989) 713-716
17. Jouanguy E., Lamhamedi-Cherradi S., Altare F., Fondanèche M.C., Tuerlinckx D., Blanche S., et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest 100 11 (1997) 2658-2664
18. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263 5153 (1994) 1612-1615
19. Kawasaki A., Kyogoku C., Ohashi J., Miyashita R., Hikami K., Kusaoi M., et al. Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis Rheum 58 3 (2008) 826-834
20. Keller C., Hoffmann R., Lang R., Brandau S., Hermann C., and Ehlers S. Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes. Infect Immun 74 7 (2006) 4295-4309
21. Ko J., Gendron-Fitzpatrick A., and Splitter G.A. Susceptibility of IFN regulatory factor-1 and IFN consensus sequence binding protein-deficient mice to brucellosis. J Immunol 168 5 (2002) 2433-2440
22. Lohoff M., Ferrick D., Mittrucker H.W., Duncan G.S., Bischof S., Rollinghoff M., et al. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6 6 (1997) 681-689
23. Macaskill P., Walter S.D., and Irwig L. A comparison of methods to detect publication bias in meta-analysis. Stat Med 20 4 (2001) 641-654
24. Negishi H., Fujita Y., Yanai H., Sakaguchi S., Ouyang X., Shinohara M., et al. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in toll-like receptor-dependent gene induction program. Proc Natl Acad Sci U S A 103 41 (2006) 15136-15141
25. Newport M.J., Awomoyi A.A., and Blackwell J.M. Polymorphism in the interferon-gamma receptor-1 gene and susceptibility to pulmonary tuberculosis in The Gambia. Scand J Immunol 58 4 (2003) 383-385
26. Oddo M., Calandra T., Bucala R., and Meyan P.R. Macrophage migration inhibitory factor reduces the growth of virulent Mycobacterium tuberculosis in human macrophages. Infect Immun 73 6 (2005) 3783-3786
27. Ogasawara K., Hida S., Azimi N., Tagaya Y., Sato T., Yokochi-Fukuda T., et al. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391 6668 (1998) 700-703
28. Ohashi J., Yamamoto S., Tsuchiya N., Hatta Y., Komata T., Matsushita M., et al. Comparison of statistical power between 2 × 2 allele frequency and allele positivity tables in case-control studies of complex disease genes. Ann Hum Genet 65 (2001) 197-206
29. Pan H., Yan B.S., Rojas M., Shebzukhov Y.V., Zhou H., Kobzik L., et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature 434 7034 (2005) 767-772
30. Pravica V., Asderakis A., Perrey C., Hajeer A., Sinnott P.J., and Hutchinson I.V. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 26 1 (1999) 1-3
31. Qiao Y., Prabhakar S., Coccia E.M., Weiden M., Canova A., Giacomini E., et al. Host defense responses to infection by Mycobacterium tuberculosis. Induction of IRF-1 and a serine protease inhibitor. J Biol Chem 277 25 (2002) 22377-22385
32. Reiling N., Hölscher C., Fehrenbach A., Kröger S., Kirschning C.J., Goyert S., et al. Cutting edge: toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 169 7 (2002) 3480-3484
33. Remoli M.E., Giacomini E., Lutfalla G., Dondi E., Orefici G., Battistini A., et al. Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis. J Immunol 169 1 (2002) 366-374
34. Sahiratmadja E., Baak-Pablo R., de Visser A.W., Alisjahbana B., Adnan I., van Crevel R., et al. Association of polymorphisms in IL-12/IFN-gamma pathway genes with susceptibility to pulmonary tuberculosis in Indonesia. Tuberculosis (Edinb) 87 4 (2007) 303-311
35. Saito H., Tada S., Wakabayashi K., Nakamoto N., Takahashi M., Nakamura M., et al. The detection of IRF-1 promoter polymorphisms and their possible contribution to T helper 1 response in chronic hepatitis C. J Interferon Cytokine Res 22 6 (2002) 693-700
36. Sato M., Taniguchi T., and Tanaka N. The interferon system and interferon regulatory factor transcription factors - studies from gene knockout mice. Cytokine Growth Factor Rev 12 2-3 (2001) 133-142
37. Sigurdsson S., Nordmark G., Go ring H.H.H., Lindroos K., Wiman A., Sturfelt G., et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76 (2005) 528-537
38. Sims S.H., Cha Y., Romine M.F., Gao P.Q., Gottlieb K., and Deisseroth A.B. A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol Cell Biol 13 1 (1993) 690-702
39. Taki S., Sato T., Ogasawara K., Fukuda T., Sato M., Hida S., et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6 6 (1997) 673-679
40. Taniguchi T., Harada H., and Lamphier M. Regulation of the interferon system and cell growth by the IRF transcription factors. J Cancer Res Clin Oncol 121 9-10 (1995) 516-520
41. Taniguchi T., Ogasawara K., Takaoka A., and Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19 (2001) 623-655
42. Tosh K., Campbell S.J., Fielding K., Sillah J., Bah B., Gustafson P., et al. Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proc Natl Acad Sci U S A 103 27 (2006) 10364-10368
43. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3 2 (2003) 133-146
44. Tso H.W., Ip W.K., Chong W.P., Tam C.M., Chiang A.K., and Lau Y.L. Association of Interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun 6 4 (2005) 358-363
45. Tufariello J.M., Chan J., and Flynn J.L. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 3 9 (2003) 578-590
46. van de Vosse E., Hoeve M.A., and Ottenhoff T.H. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis 4 12 (2004) 739-749
47. Watanabe N., and Taniguchi T. Involvement of positive (IRF-1) and negative (IRF-2) transcription factors in the gene regulation of the type I interferon system. Tanpakushitsu Kakusan Koso 37 Suppl. 14 (1992) 2813-2822
48. Williams B.G., and Dye C. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science 301 5639 (2003) 1535-1537
49. World Health Organization. The World Health Report 2004-changing history; 2004.